Literature DB >> 356725

Bactericidal activity of cephalosporins in an in vitro model simulating serum levels.

M Nishida, T Murakawa, T Kamimura, N Okada.   

Abstract

The bactericidal activity of cefazolin, cephaloridine, and cephalothin in a simulated intramuscular study (500 mg) and a simulated intravenous drip infusion study (2 g/2 h) is reported. In both model systems, the bactericidal activity of cefazolin surpassed that of cephalothin, and there were certain differences between cefazolin and cephaloridine in the simulated intramuscular study when human serum was used as a medium. In a routine reference static system, the drug levels were constant at the simulated peak level of each cephalosporin by both routes. In this system the three cephalosporins were equal in activity. In a third experiment, the effect of drug concentrations and exposure time on bactericidal activity of the cephalosporins was studied. The bactericidal activity of cephaloridine was the strongest of the three drugs when exposure time was 2 h and drug concentration was less than four times the minimal inhibitory concentration. At concentrations above four times the minimum inhibitory concentration, all three cephalosporins were equal in activity when the exposure time was 2 h.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 356725      PMCID: PMC352397          DOI: 10.1128/AAC.14.1.6

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Exudate levels and bactericidal activity of cefazolin in a new local infection system using rat granuloma pouches.

Authors:  M Nishida; T Murakawa
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

2.  Enterohepatic circulation of a new oral cephalosporin, FR10612, and its effect on serum and tissue levels in rats.

Authors:  M Nishida; T Murakawa; N Okada; H Sakamoto; Y Yokota
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

3.  A method for measurement of antibiotics in human interstitial fluid.

Authors:  J S Tan; A Trott; J P Phair; C Watanakunakorn
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

4.  Studies on protein binding of cefazolin and other antibiotics.

Authors:  T Shimizu
Journal:  Jpn J Antibiot       Date:  1974-06

5.  Concentration of antibacterial agents in interstitial tissue fluid.

Authors:  G D Chisholm; P M Waterworth; J S Calnan; L P Garrod
Journal:  Br Med J       Date:  1973-03-10

6.  Nalidixic acid: an antibacterial paradox.

Authors:  G C Crumplin; J T Smith
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

7.  Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.

Authors:  P J McDonald; W A Craig; C M Kunin
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

  7 in total
  14 in total

Review 1.  Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors:  R C Li; M Zhu; J J Schentag
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  Pharmacodynamics of S-3578, a novel cephem, in murine lung and systemic infection models.

Authors:  Shuichi Miyazaki; Kenichi Okazaki; Masakatsu Tsuji; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

Review 3.  Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases.

Authors:  P S McKinnon; S L Davis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-10       Impact factor: 3.267

Review 4.  Continuous infusion of beta-lactam antibiotics.

Authors:  W A Craig; S C Ebert
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

5.  In vitro model simulating the form of exposure of bacteria to antimicrobial drugs encountered in infection.

Authors:  M J Al-Asadi; D Greenwood; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

6.  Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model.

Authors:  I Haller
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics.

Authors:  T Murakawa; H Sakamoto; T Hirose; M Nishida
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

8.  Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.

Authors:  R Roosendaal; I A Bakker-Woudenberg; M van den Berghe-van Raffe; J C Vink-van den Berg; B M Michel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

9.  Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods.

Authors:  M E Klepser; M A Banevicius; R Quintiliani; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 10.  Impact of dosage schedule of antibiotics on the treatment of serious infections.

Authors:  I A Bakker-Woudenberg; R Roosendaal
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.